Thin filament incorporation of an engineered cardiac troponin C variant (L48Q) enhances contractility in intact cardiomyocytes from healthy and infarcted hearts.
Thin filament incorporation of an engineered cardiac troponin C variant (L48Q) enhances contractility in intact cardiomyocytes from healthy and infarcted hearts.
复制标题
工程心肌肌钙蛋白 C 变体 (L48Q) 的细丝掺入可增强健康和梗塞心脏的完整心肌细胞的收缩性。
DOI:
10.1016/j.yjmcc.2014.03.015
复制
发表时间:
2014-07
影响因子:
5
通讯作者:
Regnier, Michael
中科院分区:
文献类型:
--
作者:
Feest, Erik R.;Korte, F. Steven;Tu, An-yue;Dai, Jin;Razumova, Maria V.;Murry, Charles E.;Regnier, Michael
关键词:
Many current pharmaceutical therapies for systolic heart failure target intracellular [Ca2+] ([Ca2+]i) metabolism, or cardiac troponin C (cTnC) on thin filaments, and can have significant side-effects, including arrhythmias or adverse effects on diastolic function. In this study, we tested the feasibility of directly increasing the Ca2+ binding properties of cTnC to enhance contraction independent of [Ca2+]i in intact cardiomyocytes from healthy and myocardial infarcted (MI) hearts. Specifically, cardiac thin filament activation was enhanced through adenovirus-mediated over-expression of a cardiac troponin C (cTnC) variant designed to have increased Ca2+ binding affinity conferred by single amino acid substitution (L48Q). In skinned cardiac trabeculae and myofibrils we and others have shown that substitution of L48Q cTnC for native cTnC increases Ca2+ sensitivity of force and the maximal rate of force development. Here we introduced L48Q cTnC into myofilaments of intact cardiomyocytes via adeno-viral transduction to deliver cDNA for the mutant or wild type (WT) cTnC protein. Using video-microscopy to monitor cell contraction, relaxation, and intracellular Ca2+ transients (Fura-2), we report that incorporation of L48Q cTnC significantly increased contractility of cardiomyocytes from healthy and MI hearts without adversely affecting Ca2+ transient properties or relaxation. The improvements in contractility from L48Q cTnC expression are likely the result of enhanced contractile efficiency, as intracellular Ca2+ transient amplitudes were not affected. Expression and incorporation of L48Q cTnC into myofilaments was confirmed by Western blot analysis of myofibrils from transduced cardiomyocytes, which indicated replacement of 18±2% of native cTnC with L48Q cTnC. These experiments demonstrate the feasibility of directly targeting cardiac thin filament proteins to enhance cardiomyocyte contractility that is impaired following MI.
登录
查看更多内容
影响因子:
5
作者:
Kreutziger, Kareen L.;Piroddi, Nicoletta;Regnier, Michael
通讯作者:
Regnier, Michael
DOI:
10.1152/ajpregu.00630.2006
发表时间:
2007-03-01
影响因子:
2.8
作者:
de Tombe, Pieter P.;Belus, Alexandra;Poggesi, Corrado
通讯作者:
Poggesi, Corrado
影响因子:
2.9
作者:
Dong, Wen-Ji;Jayasundar, Jayant James;Cheung, Herbert C.
通讯作者:
Cheung, Herbert C.
DOI:
10.1073/pnas.0812536106
发表时间:
2009-08-18
影响因子:
11.1
作者:
Cazorla, Olivier;Lucas, Alexandre;Lezoualc'h, Frank
通讯作者:
Lezoualc'h, Frank
DOI:
10.1152/ajpheart.00520.2005
发表时间:
2005-11-01
影响因子:
4.8
作者:
Arteaga, GM;Warren, CM;Solaro, RJ
通讯作者:
Solaro, RJ